Diabazac is an Ayurvedic syrup that is used to manage diabetes. It is made with a blend of seven herbs, including neem, karela, jamun, gudmar, chirayta, tulsi, and bel patta. These herbs have been shown to support healthy blood sugar levels, promote insulin sensitivity, and aid in weight management. Diabazac is also easy to incorporate into your daily routine, as it comes in a liquid form. Diabazac Syrup also helps with digestion and liver function. It is also easy to incorporate into your daily routine, as it comes in a liquid form. Key features of Diabazac: Made with a blend of seven Ayurvedic herbs Supports healthy blood sugar levels Promotes insulin sensitivity Aids in weight management Easy to incorporate into your daily routine Benefits of Diabazac: Supports healthy blood sugar levels Promotes insulin sensitivity Aids in weight management Enhances digestion and liver function Easy to incorporate into your daily routine List of the seven herbs and their purported benefits: Neem: B
FORM 24D
(See rule 153)
Application for the grant / renewal of a licence to
manufacture for sale of Ayurvedic/ Siddha or Unani drugs
1 . I / We ...........................................
of .....................................................hereby apply for the
grant / renewal of a licence to manufacture Ayurvedic (including Siddha) or
Unani drugs on
the premises situated
at..........................................................…………………………….
2. Names of drugs to be manufactured (with details)
3. Names, qualifications and experience of technical staff
employed for manufacture and testing of Ayurvedic (including Siddha) or Unani
drugs .............................................
4. A fee of rupees ............................... has been
credited to the Government under the head of account
.................................... and the relevant Treasury Challan is
enclosed herewith.
Date............................................ Signature
......................................
(applicant)
Note—The application should be accompanied by a Plan of the
premises.
FORM 24E
(See rule 154A)
Application for grant or renewal of a loan licence to
manufacture for sale Ayurvedic (including Siddha) or Unani Drugs
1. I / We* ...........................................................................of**................................
hereby apply for the grant / renewal of a loan licence to manufacture Ayurvedic
(including Siddha) or Unani Drugs on the premises situated
at...................………………………………………
C/o*** ............................................................................…………………………………………
2. Names of drugs to be manufactured (with details).
3. The names, qualifications and experience of technical
staff actually connected with the manufacture and testing of Ayurvedic
(including Siddha) or Unani drugs in the manufacturing premises.
4. I / We* enclose,
(a) A true copy of a letter from me/us to the manufacturing
concern whose manufacturing capacity is intended to be utilized by me / us.
(b) A true copy of a letter from the manufacturing concern
that they agree to lend the services of their competent technical staff,
equipment and premises for the manufacture of each item required by me/us and
that they shall maintain the registers of raw materials and finished products
separately in this behalf.
(c) Specimen of labels, cartons of the drugs proposed to be
manufactured.
5. A fee of Rs
...................................................... has been credited to
Government under the head of account .................................... and
the relevant Treasury Challan is enclosed herewith.
Date
...................................... Signature ...................... ………]
(applicant)
* Enter here the name of the proprietor, partners or
Managing Director as the case may be.
**Enter here the name of the applicant firm and the address
of the principal place of business.
*** Enter here the name and address of the manufacturing
concern where the manufacture will
be actually carried out and also the licence number under
which the letter operates.
Comments
Post a Comment